Skip to main content

Table 1 Baseline characteristics of the study cohort at the beginning of the follow up period

From: Individualized treatment with denosumab in children with osteogenesis imperfecta – follow up of a trial cohort

Participants [n]

10

Male [n] (%)

7 (70)

Age Mean [years] (range)

8.6 (6.16 – 12.13)

Height Mean [cm] (range)

110.1 (65.0 – 140.0)

Height Z-Scores ± SD

-4.53 ± 4.36

Weight Mean [kg] (range)

24.8 (7.8 – 30.1)

BMI Mean [kg/m2] (SEM)

18.33 (13.1 – 34.4)

OI Type 1/4 [n] (%)

8 (80)

OI Type 1/4 able to walk (GMFM item 69) n (%)

7 (70)

OI Type 3 [n] (%)

2 (20)

OI Type 3 able to walk (GMFM item 69) n (%)

0 (0)

Causative gene

COL1A1 [n] (%)

7 (70)

COL1A2 [n] (%)

3 (30)